Glucocorticoid Therapy in Asthma

  • Joseph D. Spahn
  • Alan K. Kamada
  • Stanley J. Szefler
Part of the Current Clinical Practice book series (CCP)


GC therapy is a valuable treatment modality in the management of both acute and chronic of asthma. GCs were first used in the treatment of asthma shortly after cortisone was first synthesized and following reports that cortisone was effective in the treatment of rheumatoid arthritis. Early studies evaluating the effect of cortisone on asthma were encouraging, with significant improvements in asthma symptoms and pulmonary function. Much of the early enthusiasm for systemic GC use was dampened with the realization that chronic use of this medication resulted in multiple adverse effects. The subsequent development of effective inhaled GC preparations has revolutionized asthma care. By virtue of their high topical to systemic potency, inhaled GC therapy has proven to be safe and effective in the treatment of asthma. This chapter will provide a broad overview of the structure, mechanisms of action, pharmacokinetics, efficacy, and adverse effects associated with systemic and inhaled GC therapy in asthma.


Severe Asthma Fluticasone Propionate Asthma Symptom Acute Asthma Glucocorticoid Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McFadden ER Jr. Dosages of corticosteroids in asthma. Am Rev Respir Dis 1993; 147: 1306–1310.PubMedGoogle Scholar
  2. 2.
    Engel T, Heinig JH. Glucocorticosteroid therapy in acute asthma—a critical review. Eur Respir J 1991; 4: 881–889.PubMedGoogle Scholar
  3. 3.
    Harris JB, Weinberger MM, Nassif E, Smith G, Milavetz G, Stillerman A. Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators. J Pediatr 1987; 110: 627–633.PubMedCrossRefGoogle Scholar
  4. 4.
    Harter JG, Reddy WJ, Thom GW. Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 1963; 269: 591–596.PubMedCrossRefGoogle Scholar
  5. 5.
    Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373–381.PubMedCrossRefGoogle Scholar
  6. 6.
    Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikonder K, Persson T, Keinikoinen K, Selroos O, Stenius-Aarniala B, Svahn T, Temmivaara R, Laitinen LA. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700–705.PubMedCrossRefGoogle Scholar

Suggested Reading

  1. Chapman KR, Verbeek RP, White JG, Rebuck AS. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med 1991; 324: 788–794.PubMedCrossRefGoogle Scholar
  2. Expert Panel Report, National Heart, Lung, and Blood Institute, National Asthma Education Program. Guidelines for the diagnosis and management of asthma. 1991. Bethesda, MD: National Institutes of Health. Publication No. 91–3042.Google Scholar
  3. Fanta CH, Rossing TH, McFadden ER. Glucocorticoids in acute asthma: a critical controlled study. Am J Med 1983; 74: 845–851Google Scholar
  4. Haskell RI, Wong BM, Hansen JE. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med 1983; 143: 1324–1327.PubMedCrossRefGoogle Scholar
  5. International Consensus Report on Diagnosis and Management of Asthma. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, August 1992.Google Scholar
  6. Kamada AK, Leung DYM, Gleason MC, Hill MR, Szefler SJ. High-dose systemic glucocorticoid therapy in the treatment of severe asthma• a case of resistance and patterns of response. J Allergy Clin Immunol 1992; 90: 685–687.PubMedCrossRefGoogle Scholar
  7. Littenberg B, Gluck EH. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med. 1986; 314: 150–152Google Scholar
  8. Medical Research Council. Controlled trial of the effects of cortisone acetate in chronic asthma. Report to the medical research council by the subcommittee on clinical trials in asthma. Lancet 1956; ii: 798–803.Google Scholar
  9. Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 1993; 92: 513–518.Google Scholar
  10. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson S-A. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 1989; 84: 688–700.PubMedCrossRefGoogle Scholar
  11. Webb J, Clark TJH, Chilvers C. Time course of response to prednisolone in chronic airflow obstruction. Thorax 1981; 36: 18–21.PubMedCrossRefGoogle Scholar
  12. Webb JR. Dose response of patients to oral corticosteroid treatment during exacerbations of asthma. Br J Med 1986; 292: 1045–1047.Google Scholar
  13. Younger RE, Gerber PS, Herrod HG, Cohen RM, Crawford LV. Intravenous methylprednisolone efficacy in status asthmaticus of childhood. Pediatrics 1987; 80: 225–230.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Joseph D. Spahn
  • Alan K. Kamada
  • Stanley J. Szefler

There are no affiliations available

Personalised recommendations